CELUW Celularity Inc
Price Chart
Executive Summary
Celularity Inc. entered into a Settlement Agreement with Helena Global Investment Opportunities 1 Ltd to resolve existing claims and restructure obligations. The company paid $500,000 immediately, will make five monthly $100,000 payments, and assigned a $2,500,000 NEXGEL promissory note to Helena. Helena surrendered its Series A Convertible Preferred Stock, and its release of claims is conditional on full payment and performance.
Actionable Insight
This settlement resolves a default situation but imposes $1M in cash outflows over five months on a company with $0 market cap. Monitor Celularity's ability to make the monthly $100,000 installment payments — any missed payment triggers immediate default and reinstatement of all claims. The assignment of the NEXGEL note removes a $2.5M receivable from the company's balance sheet.
Key Facts
- Celularity paid $500,000 cash at closing and owes $500,000 in five monthly installments of $100,000 each.
- Celularity assigned a $2,500,000 promissory note from NEXGEL to Helena as part of the settlement.
- Helena surrendered its Series A Convertible Preferred Stock.
- Helena's release of claims is conditional on receipt of all cash payments and the NEXGEL note assignment deliverables.
- Any failure to pay an installment on time constitutes an immediate Event of Default without cure period.
- The existing security agreement remains in full force until all obligations are paid in full.
Financial Impact
Celularity must pay $1,000,000 in cash ($500,000 immediate + $500,000 over 5 months) and assign a $2,500,000 promissory note receivable to settle claims with a single creditor.
Risk Factors
- Celularity may fail to make monthly installment payments, triggering immediate default and reinstatement of all claims.
- The $1M cash outflow and loss of the $2.5M NEXGEL note receivable further strain liquidity.
- No cure period for missed payments — any default accelerates all remedies under the security agreement.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-025646 |
| Document: form8-k.htm | 0001493152-26-025646 |
| Document: 0001493152-26-025646-index-headers.html | 0001493152-26-025646 |
| Document: 0001493152-26-025646-index.html | 0001493152-26-025646 |
| Document: 0001493152-26-025646.txt | 0001493152-26-025646 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
11d ago
|
8-K
| $0.008700 $0.008700 | · 0.00% | ▲ +2.60% | $0.008700 (+0.00%) |
|
May 28, 2026
17d ago
|
8-K
| $0.008700 $0.008700 | · 0.00% | ▲ +0.26% | $0.008700 (−0.00%) |
|
Apr 21, 2026
7w ago
|
8-K
| $0.008700 $0.008700 | · 0.00% | ▲ +1.02% | $0.008700 (−0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access